These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37141919)

  • 1. Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome.
    Jiang L; Ruan X; Li Y; Gu M; Cheng J; Wang Y; Yang Y; Xu C; Wang Z; Liu L; Mueck AO
    Gynecol Endocrinol; 2023 Dec; 39(1):2206927. PubMed ID: 37141919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome.
    Halder A; Kumar H; Sharma M; Jain M; Kalsi AK; Pandey S
    Indian J Med Res; 2023 Oct; 158(4):397-406. PubMed ID: 37991331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?
    Li M; Ruan X; Ju R; Min M; Xu Z; Luo S; Wang H; Mueck AO
    Gynecol Endocrinol; 2022 Feb; 38(2):148-152. PubMed ID: 34994668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
    Peigné M; Simon V; Pigny P; Mimouni NEH; Martin C; Dewailly D; Catteau-Jonard S; Giacobini P
    Hum Reprod; 2023 May; 38(5):938-950. PubMed ID: 36921289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
    Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
    Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome.
    Sathyapalan T; Al-Qaissi A; Kilpatrick ES; Dargham SR; Keevil B; Atkin SL
    Sci Rep; 2018 Feb; 8(1):3795. PubMed ID: 29491484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
    Vural F; Vural B; Kardaş E; Ertürk Coşkun AD; Yildirim İ
    Arch Gynecol Obstet; 2023 Apr; 307(4):1083-1090. PubMed ID: 36565362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-Müllerian hormone.
    Casadei L; Fanisio F; Sorge RP; Collamarini M; Piccolo E; Piccione E
    Arch Gynecol Obstet; 2018 Jul; 298(1):207-215. PubMed ID: 29802450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.
    Woo HY; Kim KH; Rhee EJ; Park H; Lee MK
    Endocr J; 2012; 59(9):781-90. PubMed ID: 22673409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
    Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
    Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.
    Piltonen TT; Allegranza D; Hund M; Buck K; Sillman J; Arffman RK
    JMIR Res Protoc; 2024 Feb; 13():e48854. PubMed ID: 38319689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study.
    Zhang M; Liu X; Xu X; Li J; Bu Z; Yang Q; Shi H; Niu W; Dai S; Liang Y; Guo Y
    Reprod Biol Endocrinol; 2023 Feb; 21(1):15. PubMed ID: 36726106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK; Oh JY; Lee H; Sung YA
    Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.